Your Checkup: Patient Education Health Podcast Titelbild

Your Checkup: Patient Education Health Podcast

Your Checkup: Patient Education Health Podcast

Von: Ed Delesky MD and Nicole Aruffo RN
Jetzt kostenlos hören, ohne Abo

Das größte Angebot der Saison | 0,99 € pro Monat für die ersten 3 Monate + 15 € Audible-Guthaben

Danach 6,99 €/Monat. Bedingungen gelten. Monatlich kündbar.
Über diesen Titel

Ever leave the doctor’s office more confused than when you walked in? Your Checkup: Health Conversations for Motivated Patients is your health ally in a world full of fast appointments and even faster Google searches. Each week, a board certified family medicine physician and a pediatric nurse sit down to answer the questions your doctor didn’t have time to.


From understanding diabetes and depression to navigating obesity, high blood pressure, and everyday wellness—we make complex health topics simple, human, and actually useful. Whether you’re managing a condition, supporting a loved one, or just curious about your body, this podcast helps you get smart about your health without needing a medical degree.

Because better understanding leads to better care—and you deserve both.







© 2026 Your Checkup: Patient Education Health Podcast
Hygiene & gesundes Leben Persönliche Entwicklung Persönlicher Erfolg
  • 138: Lung Cancer Screening for You, a Loved One, or a Neighbor?
    Nov 16 2026

    Lung cancer is one of the scariest words in medicine, partly because it can grow quietly for years. That’s why we wanted to sit down with Chloe Mathew, a physician associate in thoracic surgery in the Philadelphia area, to walk through lung cancer screening step by step and make it feel less mysterious and a lot more doable. We keep it practical, patient-centered, and honest about what people are actually worried about when someone mentions a CT scan.

    We talk about who qualifies for a low-dose CT lung cancer screening, including the age range (50 to 80), the pack-year calculation (20 pack-years or more). Chloe explains how screening programs can take pressure off overwhelmed primary care visits, what a shared decision-making visit looks like, and what happens from check-in to walking out of the imaging center. We also break down why screening CTs are low-dose, when symptoms call for a diagnostic CT, and how radiation concerns fit into real-world risk.

    If you’ve ever seen the word “nodule” on a report and spiraled, we spend real time there. Chloe explains Lung-RADS categories, why a six-month follow-up scan can be the smartest way to get answers, and why many lung nodules are benign (like granulomas from old infections). We also talk openly about smoking stigma, how shame keeps people from seeking care, and a concrete resource for quitting: 1-800-QUIT-NOW, which can connect you to free support in your state.

    If this helped you, share it with a friend or family member who has a smoking history, and please subscribe and leave a review so more people can find clear, trustworthy guidance on lung cancer screening.

    Send us a (voice ) message with this link, we would love to hear from you. Standard message rates may apply.

    Support the show

    Production and Content: Edward Delesky, MD, DABOM & Nicole Aruffo, RN

    Artwork Rebrand and Avatars:

    Vantage Design Works (Vanessa Jones)

    Website: https://www.vantagedesignworks.com/

    Instagram: https://www.instagram.com/vantagedesignworks?igsh=aHRuOW93dmxuOG9m&utm_source=qr


    Original Artwork Concept: Olivia Pawlowski

    Mehr anzeigen Weniger anzeigen
    42 Min.
  • 137: GLP Maintenance Dosing and Microdosing
    Nov 9 2026

    We break down the real middle ground between staying on a full GLP-1 dose and stopping abruptly, using the “ladder, not a switch” mindset for long-term weight loss maintenance. We share what the newest evidence says about lower maintenance doses, spacing injections, tapering safely, and why DIY microdosing can create serious risks.
    • the ladder approach to GLP-1 treatment decisions
    • why stopping GLP-1s cold turkey often leads to regain and worsening blood sugar and blood pressure
    • what Surmount Maintain suggests about low-dose tirzepatide maintenance after a plateau
    • how maintenance dosing can preserve weight loss and improve A1C in people with prediabetes
    • the pharmacology behind spacing injections and what early models and small case data show
    • oral Wegovy dosing options, cost realities, and why access drives real-world choices
    • slow tapering as a safer off-ramp while monitoring hunger and weight trend
    • why microdosing by “click counting” lacks solid evidence and raises safety concerns
    • how insurance coverage changes can force medication switches and disrupt continuity of care
    You can find us on Threads, Instagram, or send us some fan mail. But most importantly, stay healthy, my friends.


    Send us a (voice ) message with this link, we would love to hear from you. Standard message rates may apply.

    Support the show

    Production and Content: Edward Delesky, MD, DABOM & Nicole Aruffo, RN

    Artwork Rebrand and Avatars:

    Vantage Design Works (Vanessa Jones)

    Website: https://www.vantagedesignworks.com/

    Instagram: https://www.instagram.com/vantagedesignworks?igsh=aHRuOW93dmxuOG9m&utm_source=qr


    Original Artwork Concept: Olivia Pawlowski

    Mehr anzeigen Weniger anzeigen
    38 Min.
  • 136: What Happens After You Stop a GLP1?
    Nov 2 2026

    We break down what the research says happens after stopping GLP-1 medications like semaglutide and tirzepatide, including the scale, hunger signals, and key lab changes. We explain the biology behind rebound and why weight regain is predictable physiology rather than a willpower problem.
    • GLP-1s as long-term management for obesity and type 2 diabetes, not a cure
    • what GLP-1 does in the brain, stomach, and pancreas and what reverses after stopping
    • STEP 1 extension numbers showing about two-thirds regain over a year after stopping Wegovy
    • meta-analysis findings on average regain after semaglutide or tirzepatide
    • why bigger losses often come with bigger rebounds and why regain is typically gradual
    • body composition concerns, regain tending to be more fat than muscle
    • what happens to A1C, fasting glucose, blood pressure, and cholesterol after discontinuation
    • set point, metabolic adaptation, and counter-regulatory appetite signals
    • legitimate reasons people stop and why stopping should be a planned transition
    You can find us on Instagram, threads. You can send us an in um a voicemail.


    Send us a (voice ) message with this link, we would love to hear from you. Standard message rates may apply.

    Support the show

    Production and Content: Edward Delesky, MD, DABOM & Nicole Aruffo, RN

    Artwork Rebrand and Avatars:

    Vantage Design Works (Vanessa Jones)

    Website: https://www.vantagedesignworks.com/

    Instagram: https://www.instagram.com/vantagedesignworks?igsh=aHRuOW93dmxuOG9m&utm_source=qr


    Original Artwork Concept: Olivia Pawlowski

    Mehr anzeigen Weniger anzeigen
    32 Min.
adbl_web_anon_alc_button_suppression_t1
Noch keine Rezensionen vorhanden